EFG Asset Management North America Corp. Trims Stock Holdings in Cytokinetics, Incorporated $CYTK

EFG Asset Management North America Corp. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 4.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 80,359 shares of the biopharmaceutical company’s stock after selling 3,503 shares during the period. EFG Asset [...]